Anne K Volkmer

The CD47-signal regulatory protein alpha (SIRPa) interaction is a therapeutic target for human solid tumors

Jens-Peter Volkmer, Debashis Sahoo, Theresa A. Storm, 2012, Proceedings of the National Academy of Sciences.

Combination of a MDR1-targeted replicative adenovirus and chemotherapy for the therapy of pretreated ovarian cancer

G. Bauerschmitz, T. Schöndorf, W. Janni, 2011, Journal of Cancer Research and Clinical Oncology.

Disrupting the CD47-SIRPα anti-phagocytic axis by a humanized anti-CD47 antibody is an efficacious treatment for malignant pediatric brain tumors

Theresa A. Storm, Patricia A. Lovelace, I. Weissman, 2017, Science Translational Medicine.

Antibody therapy targeting the CD47 protein is effective in a model of aggressive metastatic leiomyosarcoma

Andrew H. Beck, R. West, I. Weissman, 2012, Proceedings of the National Academy of Sciences.

Improving macrophage responses to therapeutic antibodies by molecular engineering of SIRPα variants

I. Weissman, K. Garcia, J. Volkmer, 2013, Oncoimmunology.